Immunogenicity of mesenchymal stromal/stem cells

Area of Science:

• Stem Cell Biology
• Immunology
• Regenerative Medicine

Background:

• Mesenchymal stromal cells (MSCs) possess self-renewal and differentiation capabilities.
• MSCs exhibit anti-inflammatory and immunomodulatory effects, making them promising for treating various diseases.
• Their ready availability contrasts with other stem cell sources, enhancing their therapeutic potential.

Purpose of the Study:

• To analyze and discuss the safety of MSCs concerning their immunogenicity.
• To provide a reference for future research and clinical applications of MSCs.

Main Methods:

• Literature review and analysis of existing data on MSC immunogenicity.
• Discussion of immune rejection as a challenge in MSC-based therapies.

Main Results:

• MSCs are considered to have low immunogenicity but do not possess full immunological privilege.
• Immune rejection remains a significant concern for MSC therapeutic applications.

Conclusions:

• Further investigation into MSC immunogenicity is crucial for safe and effective clinical translation.
• Understanding MSC immunogenicity is key to overcoming immune rejection barriers in cell-based therapies.